Arrowhead Pharmaceuticals
ARWR
#2117
Rank
ยฃ6.79 B
Marketcap
ยฃ48.73
Share price
-0.58%
Change (1 day)
215.28%
Change (1 year)

Market capitalization of Arrowhead Pharmaceuticals (ARWR)

Market cap: ยฃ6.79 Billion

As of January 2026 Arrowhead Pharmaceuticals has a market cap of ยฃ6.79 Billion. This makes Arrowhead Pharmaceuticals the world's 2117th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arrowhead Pharmaceuticals from 1997 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ6.79 B-5.68%
2025ยฃ7.20 B283.12%
2024ยฃ1.88 B-27.14%
2023ยฃ2.58 B-32.37%
2022ยฃ3.81 B-25.68%
2021ยฃ5.13 B-11.24%
2020ยฃ5.78 B18.27%
2019ยฃ4.89 B439.86%
2018ยฃ0.90 B344.64%
2017ยฃ0.20 B118.67%
2016ยฃ93.17 M-62.35%
2015ยฃ0.24 B-4.59%
2014ยฃ0.25 B1.1%
2013ยฃ0.25 B1138.56%
2012ยฃ20.71 M-27%
2011ยฃ28.37 M-31.84%
2010ยฃ41.63 M102.44%
2009ยฃ20.56 M-23.7%
2008ยฃ26.95 M-63.41%
2007ยฃ73.66 M-3.77%
2006ยฃ76.54 M-7.5%
2005ยฃ82.75 M160.54%
2004ยฃ31.76 M53692.92%
2003ยฃ0.05 M199.13%
2002ยฃ0.01 M-63.83%
2001ยฃ0.05 M-74.58%
2000ยฃ0.21 M38.28%
1999ยฃ0.15 M-2.01%
1998ยฃ0.15 M62.96%
1997ยฃ0.09 M

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Arrowhead Pharmaceuticals was reported to be:

ยฃ6.62 Billion
by Nasdaq info icon info icon
ยฃ6.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alnylam Pharmaceuticals
ALNY
ยฃ36.34 B 434.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.21 B-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ2.76 B-59.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
ยฃ81.73 M-98.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ382.72 B 5,533.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
ยฃ11.50 B 69.33%๐Ÿ‡บ๐Ÿ‡ธ USA